Nodular lymphocyte predominant Hodgkin lymphoma - An immunophenotypic reappraisal based on a single-institution experience

被引:18
|
作者
Uherova, P [1 ]
Valdez, R [1 ]
Ross, CW [1 ]
Schnitzer, B [1 ]
Finn, WG [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
nodular lymphocyte predominant Hodgkin lymphoma; immunohistochemistry;
D O I
10.1309/38RK238FCDCH5R22
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In our experience, certain commonly cited immunophenotypic features of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL) are not encountered in day-to-day practice. We reviewed 60 cases of NLPHL (18 women, 42 men; median age, 34 years) to discern immunophenotypic features from a large, single-institution cohort. All cases contained lymphocytic and histiocytic (L&H) cells. These cells expressed CD20 in 98% (59160), CD79a (usually faint) in 87% (27131), CD30 in 7% (4159), epithelial membrane antigen in 21% (12156), bcl-2 in 5% (2141), and bcl-6 in 83% (30136) of cases. CD10 was negative in all 36 cases studied; 100% of cases (55155) demonstrated CD3+ rosettes. Although CD57+ T cells were common within the background infiltrate, CD57+ rosettes were seen in only 48% of cases (15131) and were rare when encountered. Based on these patterns, we conclude that bcl-2 and bcl-6 may be useful additions to the immunophenotypic analysis of NLPHL, but that the diagnostic usefulness of epithelial membrane antigen and CD57 rosettes may have been overemphasized in previous reports.
引用
收藏
页码:192 / 198
页数:7
相关论文
共 50 条
  • [31] Mummified cells in nodular lymphocyte predominant Hodgkin lymphoma
    Matthew M. Klairmont
    Joel F. Gradowski
    Journal of Hematopathology, 2020, 13 : 73 - 74
  • [32] Treatment of nodular lymphocyte-predominant Hodgkin lymphoma
    Eichenauer, Dennis A.
    Eich, Hans Theodor
    Engert, Andreas
    ONKOLOGIE, 2022, 28 (10): : 908 - 913
  • [33] Treatment Strategies in Nodular Lymphocyte Predominant Hodgkin Lymphoma
    Advani, Ranjana
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S168 - S169
  • [34] Nodular lymphocyte predominant Hodgkin lymphoma: Experience of Polish Pediatric Leukemia/Lymphoma Study Group
    Klekawka, Tomasz
    Balwierz, Walentyna
    Brozyna, Agnieszka
    Chaber, Radoslaw
    Dadela-Urbanek, Agnieszka
    Koltan, Andrzej
    Kwasnicka, Justyna
    Mitura-Lesiuk, Malgorzata
    Muszynska-Roslan, Katarzyna
    Przybyszewski, Borys
    Ruranska, Iwona
    Smalisz, Katarzyna
    Mizia-Malarz, Agnieszka
    Stachowicz-Stencel, Teresa
    Stolarska, Malgorzata
    Wziatek, Agnieszka
    Zielezinska, Katarzyna
    Skoczen, Szymon
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2021, 38 (07) : 609 - 619
  • [35] Nodular Lymphocyte Predominant Hodgkin Lymphoma - experience of Polish Pediatric Leukemia/Lymphoma Study Group
    Klekawka, T.
    Moryl-Bujakowska, A.
    Smalisz, K.
    Brozyna, A.
    Kwasnicka, J.
    Chaber, R.
    Ruranska, I
    Wziatek, A.
    Mitura-Lesiuk, M.
    Stachowicz-Stencel, T.
    Koltan, A.
    Muszynska-Roslan, K.
    Stolarska, M.
    Mizia-Malarz, A.
    Woszczyk, M.
    Urbanek-Dadela, A.
    Przybyszewski, B.
    Zielezinska, K.
    Balwierz, W.
    KLINISCHE PADIATRIE, 2020, 232 (02): : 93 - 94
  • [36] Large B-cell transformation in nodular lymphocyte-predominant Hodgkin lymphoma: 40-year experience from a single institution
    Kenderian, Saad Sirop
    Habermann, Thomas M.
    Macon, William R.
    Ristow, Kay M.
    Ansell, Stephen M.
    Colgan, Joseph P.
    Johnston, Patrick B.
    Inwards, David J.
    Markovic, Svetomir N.
    Micallef, Ivana N.
    Thompson, Carrie A.
    Porrata, Luis F.
    Martenson, James A.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    BLOOD, 2016, 127 (16) : 1960 - 1966
  • [37] MULTICENTRIC ITALIAN EXPERIENCE IN TREATMENT OF NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA IN THE RITUXIMAB ERA
    Gotti, M.
    Merli, F.
    Re, A.
    Rusconi, C.
    Pulsoni, A.
    Rigacci, L.
    Merli, M.
    Liberati, M.
    Ferretti, V.
    Zoboli, V.
    Fama, A.
    Dalceggio, D.
    Meli, E.
    Annechini, G.
    Puccini, B.
    Ferrario, A.
    Appolloni, V.
    Sciarra, R.
    Frigeni, M.
    Arcaini, L.
    Bonfichi, M.
    HAEMATOLOGICA, 2016, 101 : 16 - 16
  • [38] Frontline Therapy of Nodular Lymphocyte Predominant Hodgkin Lymphoma with Rituximab: The Stanford University Experience
    Advani, Ranjana H.
    Horning, Sandra J.
    Hoppe, Richard T.
    Daadi, Sarah
    Allen, John
    Natkunam, Yasodha
    McMillan, Alex
    Bartlett, Nancy L.
    BLOOD, 2011, 118 (21) : 1154 - 1154
  • [39] Coexisting and Clonally Identical Classic Hodgkin Lymphoma and Nodular Lymphocyte Predominant Hodgkin Lymphoma
    Song, Joo Y.
    Eberle, Franziska C.
    Xi, Liqiang
    Raffeld, Mark
    Rahma, Osama
    Wilson, Wyndham H.
    Dunleavy, Kieron
    Pittaluga, Stefania
    Jaffe, Elaine S.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2011, 35 (05) : 767 - 772
  • [40] Metachronous and clonally related classic Hodgkin lymphoma and nodular lymphocyte predominant Hodgkin lymphoma
    Ding, Yi
    Campbell, Andrew
    Zhang, Xuan
    Fu, Kai
    Yuan, Ji
    PATHOLOGY, 2021, 53 (02) : 285 - 288